120 related articles for article (PubMed ID: 23276822)
1. Maintenance treatment with different strategies in advanced non-small-cell lung cancer: a systematic review and meta-analysis.
Cai H; Lin Y; Li W; Li X
Clin Lung Cancer; 2013 Jul; 14(4):333-41. PubMed ID: 23276822
[TBL] [Abstract][Full Text] [Related]
2. The impact of clinical characteristics on outcomes from maintenance therapy in non-small cell lung cancer: A systematic review with meta-analysis.
Zhou F; Jiang T; Ma W; Gao G; Chen X; Zhou C
Lung Cancer; 2015 Aug; 89(2):203-11. PubMed ID: 26115839
[TBL] [Abstract][Full Text] [Related]
3. Maintenance Therapy Improves Survival Outcomes in Patients with Advanced Non-small Cell Lung Cancer: A Meta-analysis of 14 Studies.
Lu S; Yu Y; Chen Z; Ye X; Li Z; Niu X
Lung; 2015 Oct; 193(5):805-14. PubMed ID: 26119960
[TBL] [Abstract][Full Text] [Related]
4. Maintenance therapy with continuous or switch strategy in advanced non-small cell lung cancer: a systematic review and meta-analysis.
Zhang X; Zang J; Xu J; Bai C; Qin Y; Liu K; Wu C; Wu M; He Q; Zhang S; Wei L; He J
Chest; 2011 Jul; 140(1):117-126. PubMed ID: 21436247
[TBL] [Abstract][Full Text] [Related]
5. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Tumor Vaccines and Cellular Immunotherapies in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Dammeijer F; Lievense LA; Veerman GD; Hoogsteden HC; Hegmans JP; Arends LR; Aerts JG
J Clin Oncol; 2016 Sep; 34(26):3204-12. PubMed ID: 27432922
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of combining targeted therapy with pemetrexed or docetaxel as second-line treatment in patients with advanced non-small-cell lung cancer: a meta-analysis of 14 randomized controlled trials.
Li X; Wang H; Lin W; Xu Q
Curr Med Res Opin; 2014 Nov; 30(11):2295-304. PubMed ID: 24701984
[TBL] [Abstract][Full Text] [Related]
8. Maintenance or Consolidation Therapy for Non--Small-Cell Lung Cancer: A Meta-Analysis Involving 5841 Subjects.
Zhang C; Huang C; Wang J; Wang X; Li K
Clin Lung Cancer; 2015 Sep; 16(5):e15-23. PubMed ID: 25676720
[TBL] [Abstract][Full Text] [Related]
9. Maintenance or consolidation therapy in small-cell lung cancer: a systematic review and meta-analysis.
Rossi A; Garassino MC; Cinquini M; Sburlati P; Di Maio M; Farina G; Gridelli C; Torri V
Lung Cancer; 2010 Nov; 70(2):119-28. PubMed ID: 20188431
[TBL] [Abstract][Full Text] [Related]
10. Single agent maintenance therapy for advanced stage non-small cell lung cancer: a meta-analysis.
Behera M; Owonikoko TK; Chen Z; Kono SA; Khuri FR; Belani CP; Ramalingam SS
Lung Cancer; 2012 Aug; 77(2):331-8. PubMed ID: 22546678
[TBL] [Abstract][Full Text] [Related]
11. The role of maintenance therapy in the treatment of elderly non-small-cell lung cancer patients: a meta-analysis of randomized controlled trials.
Zhang L; Gao S; He J
Drug Des Devel Ther; 2017; 11():3435-3440. PubMed ID: 29238168
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of chemotherapy or tyrosine kinase inhibitors combined with bevacizumab versus chemotherapy or tyrosine kinase inhibitors alone in the treatment of non-small cell lung cancer: a systematic review and meta-analysis.
Sun L; Ma JT; Zhang SL; Zou HW; Han CB
Med Oncol; 2015 Feb; 32(2):473. PubMed ID: 25603953
[TBL] [Abstract][Full Text] [Related]
13. Erlotinib-based targeted dual agent versus erlotinib alone in previously treated advanced non-small-cell lung cancer: a meta-analysis of 13 randomized controlled trials.
Yu S; Xu Q; Yuan Y; Li X; Cai H
Curr Med Res Opin; 2016 Dec; 32(12):1927-1934. PubMed ID: 27479336
[TBL] [Abstract][Full Text] [Related]
14. Erlotinib as maintenance therapy in patients with advanced non-small cell lung cancer: a pooled analysis of three randomized trials.
Petrelli F; Borgonovo K; Cabiddu M; Barni S
Anticancer Drugs; 2011 Nov; 22(10):1010-9. PubMed ID: 21970852
[TBL] [Abstract][Full Text] [Related]
15. The Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Molecularly Selected Patients with Non-Small Cell Lung Cancer: A Meta-Analysis of 30 Randomized Controlled Trials.
Liu J; Sheng Z; Zhang Y; Li G
Target Oncol; 2016 Feb; 11(1):49-58. PubMed ID: 26206590
[TBL] [Abstract][Full Text] [Related]
16. Single-agent maintenance therapy in non-small cell lung cancer: a systematic review and meta-analysis.
Yuan DM; Wei SZ; Lü YL; Zhang Y; Miao XH; Zhan P; Yu LK; Shi Y; Song Y
Chin Med J (Engl); 2012 Sep; 125(17):3143-9. PubMed ID: 22932196
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of pemetrexed-based doublet therapy compared to pemetrexed alone for the second-line treatment of advanced non-small-cell lung cancer: an updated meta-analysis.
Zhong A; Xiong X; Shi M; Xu H
Drug Des Devel Ther; 2015; 9():3685-93. PubMed ID: 26229433
[TBL] [Abstract][Full Text] [Related]
18. The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials.
Li BT; Barnes TA; Chan DL; Naidoo J; Lee A; Khasraw M; Marx GM; Kris MG; Clarke SJ; Drilon A; Rudin CM; Pavlakis N
Lung Cancer; 2016 Dec; 102():21-27. PubMed ID: 27987583
[TBL] [Abstract][Full Text] [Related]
19. PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer.
Paz-Ares LG; de Marinis F; Dediu M; Thomas M; Pujol JL; Bidoli P; Molinier O; Sahoo TP; Laack E; Reck M; Corral J; Melemed S; John W; Chouaki N; Zimmermann AH; Visseren-Grul C; Gridelli C
J Clin Oncol; 2013 Aug; 31(23):2895-902. PubMed ID: 23835707
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of erlotinib in patients with advanced non-small cell lung cancer: a pooled analysis of randomized trials.
Gao H; Ding X; Wei D; Cheng P; Su X; Liu H; Aziz F; Wang D; Zhang T
Anticancer Drugs; 2011 Oct; 22(9):842-52. PubMed ID: 21808188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]